Impact of treating iron deficiency, diagnosed according to hepcidin quantification, on outcomes after a prolonged ICU stay compared to standard care: a multicenter, randomized, single-blinded trial

BACKGROUND: Anemia is a significant problem in patients on ICU. Its commonest cause, iron deficiency (ID), is difficult to diagnose in the context of inflammation. Hepcidin is a new marker of ID. We aimed to assess whether hepcidin levels would accurately guide treatment of ID in critically ill anem...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Crit Care
Autori principali: Lasocki, Sigismond, Asfar, Pierre, Jaber, Samir, Ferrandiere, Martine, Kerforne, Thomas, Asehnoune, Karim, Montravers, Philippe, Seguin, Philippe, Peoc’h, Katell, Gergaud, Soizic, Nagot, Nicolas, Lefebvre, Thibaud, Lehmann, Sylvain
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7885380/
https://ncbi.nlm.nih.gov/pubmed/33588893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-03430-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi